Chimerix Inc

NASDAQ:CMRX   3:59:51 PM EDT
6.29
+0.43 (+7.34%)
4:03:29 PM EDT: $6.29 0.00 (0.00%)
Products, Community

FDA Says Approved Tembexa (Brincidofovir) To Treat Smallpox

Published: 06/04/2021 17:41 GMT
Chimerix Inc (CMRX) - Approved Tembexa (brincidofovir) to Treat Smallpox.
Granted Approval of Tembexa to Chimerix Inc.further Company Coverage: Cmrxo ((reuters.
Briefs@thomsonreuters.
Com;)).